Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

The effect of smoking lingers

Publish date:: October 20, 2019

Key clinical point: No amount of smoking appears to be safe.

Major finding: Former smokers had an increased yearly decline in FEV₁ of 1.82 mL.

Study details: Cohort study of 25,352 smokers, former smokers, and never-smokers.

Disclosures: The study authors report personal fees, consultancy fees, or grants from a wide variety of pharmaceutical companies.

Citation:

Oelsner EC et al. Lancet Respir Med. 2019 Oct 9. doi: 10.1016/S2213-2600(19)30276-0.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Preventive Care

Sedentary postmenopausal women have higher heart failure risk,

Don’t miss cardiovascular risk factors in transgender patients,

Artificially sweetened drinks add to CVD risk,

Combined features of benign breast disease tied to breast cancer risk,

Psychosocial resilience associated with better cardiovascular health in Blacks,

All Specialties